These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 19126992)
1. Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients. Koltai K; Feher G; Kenyeres P; Lenart I; Alexy T; Horvath B; Marton Z; Kesmarky G; Toth K Clin Hemorheol Microcirc; 2008; 40(4):295-302. PubMed ID: 19126992 [TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744 [TBL] [Abstract][Full Text] [Related]
3. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke. Pongrácz E Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349 [TBL] [Abstract][Full Text] [Related]
4. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects. Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229 [TBL] [Abstract][Full Text] [Related]
5. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients. Koltai K; Papp J; Kenyeres P; Feher G; Tibold A; Alexy T; Marton Z; Kesmarky G; Toth K Biorheology; 2014; 51(2-3):197-206. PubMed ID: 24898335 [TBL] [Abstract][Full Text] [Related]
7. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100. Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939 [TBL] [Abstract][Full Text] [Related]
8. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527 [TBL] [Abstract][Full Text] [Related]
9. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496 [TBL] [Abstract][Full Text] [Related]
10. Response to aspirin and clopidogrel monitored with different platelet function methods. Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602 [TBL] [Abstract][Full Text] [Related]
11. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480 [TBL] [Abstract][Full Text] [Related]
12. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study. Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. Ang L; Palakodeti V; Khalid A; Tsimikas S; Idrees Z; Tran P; Clopton P; Zafar N; Bromberg-Marin G; Keramati S; Mahmud E J Am Coll Cardiol; 2008 Sep; 52(13):1052-9. PubMed ID: 18848137 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor. Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433 [TBL] [Abstract][Full Text] [Related]
16. The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level. Vasilieva E; Kasyanova O; Shpektor A Acute Card Care; 2008; 10(3):181-4. PubMed ID: 18608041 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353 [TBL] [Abstract][Full Text] [Related]
18. ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay. Schäfer A; Weinberger S; Flierl U; Eigenthaler M; Störk S; Walter U; Ertl G; Bauersachs J Thromb Haemost; 2008 Oct; 100(4):618-25. PubMed ID: 18841284 [TBL] [Abstract][Full Text] [Related]
19. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis? von Lewinski F; Riggert J; Paulus W J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186 [TBL] [Abstract][Full Text] [Related]
20. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Buresly K; Eisenberg MJ; Zhang X; Pilote L Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]